Oprea-Lager, Daniela-Elena http://orcid.org/0000-0001-9447-2305
Gontier, Eric
García-Cañamaque, Lina
Gauthé, Mathieu
Olivier, Pierre
Mitjavila, Mercedes
Tamayo, Pilar
Robin, Philippe
García Vicente, Ana Maria
Bouyeure, Anne-Charlotte
Bailliez, Alban
Rodríguez-Fernández, Antonio
Mahmoud, Sinan Ben
Vallejo-Casas, Juan Antonio
Maksud, Philippe
Merlin, Charles
Blanc-Durand, Paul
Drouet, Clément
Tissot, Hubert
Vierasu, Irina
Vander Borght, Thierry
Boos, Evelyne
Chossat, Florence
Hodolic, Marina
Rousseau, Caroline
Funding for this research was provided by:
Curium
Article History
Received: 18 May 2023
Accepted: 5 June 2023
First Online: 21 June 2023
Declarations
:
: This study was performed in line with the principles of the Declaration of Helsinki and its later amendments, as well as in accordance with the Good Clinical Practices (GCP), ICH E6(R2) Guidelines (CPMP/ICH/135/95 of December 1, 2016), the applicable regulations and the ethics policy of the Sponsor.The Investigator prepared and maintained complete and accurate study documents in compliance with GCP standards and local laws, rules and regulations for each subject participating in the study. Approval was granted by the Ethics Committee of participant centers in France (IRB number CPP 2020- 038 B), Belgium (IRB number P2020/199), Spain (IRB number 2020-PSMA Python), and in the Netherlands (IRB number NL72802.029.20). Informed consent was obtained from all individual participants included in the study.
: Each participant provided consent for study participation. The authors affirm that human research participants provided informed consent for publication of the images in Supplemental Fig. InternalRef removed.
: Each author provided consent for data publication.
: DOL reports unrestricted grants from Janssen, outside the submitted work, speaker honoraria from EANM, ESMO and EAU, and travel support from Bayer. CM reports travel support, consultant honoraria from Janssen and Novartis AAA, speaker honoraria from Pfizer, Astellas and Bayer; travel support from Curium. PBD reports consultant honoraria for PAIRE, Paris, France. CD reports speaker honoraria from AAA Novartis and Janssen-Cilag, and travel/congress support from AAA Novartis. CR has received personal fees and non-financial support from Curium, Novartis and Astellas. MH, FC and EB are employees of Curium. Authors EG, LGC, MG, PO, MM, PT, PR, AMGV, AB, ARF, SBM, JAVC, PM, HT, IV, TVB reports have no relevant financial or non-financial interests to disclose.